Home / Publications / World First as AI-designed Drug Starts Clinical T...

World First as AI-designed Drug Starts Clinical Trials 

06/02/2020

The UK-based AI drug discovery company, Exscientia, has been hailed as reaching a huge milestone: the world’s first AI-designed drug to enter Phase 1 clinical trials. Why is this a big deal? And are computer-designed drugs a good thing? Exscientia’s announcement...

Read more

Authors

Portrait ofCarina Healy
Carina Healy
Partner
Glasgow
Portrait ofDavid Dennis
David Dennis
Partner
Glasgow
Rachel Morrison